These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29745214)

  • 1. Imaging in the evaluation of response to treatment in oncology.
    Bisi G
    Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):127-128. PubMed ID: 29745214
    [No Abstract]   [Full Text] [Related]  

  • 2. Bridging imaging and therapy: the role of medical physics in development of precision cancer care.
    Malinen E; Hysing LB; Waldeland E; Muren LP
    Acta Oncol; 2017 Jun; 56(6):757-760. PubMed ID: 28464737
    [No Abstract]   [Full Text] [Related]  

  • 3. A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy.
    Howard SA; Krajewski KM; Jagannathan JP; Braschi-Amirfarzan M; Tirumani SH; Shinagare AB; Ramaiya NH
    AJR Am J Roentgenol; 2016 Jul; 207(1):4-14. PubMed ID: 27065346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
    Sheikhbahaei S; Mena E; Pattanayak P; Taghipour M; Solnes LB; Subramaniam RM
    PET Clin; 2017 Jan; 12(1):105-118. PubMed ID: 27863562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors.
    Rosen MA; Sullivan D
    J Clin Oncol; 2010 Apr; 28(10):e159-60; author reply e161. PubMed ID: 20159810
    [No Abstract]   [Full Text] [Related]  

  • 6. PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.
    Dimitrakopoulou-Strauss A
    Future Oncol; 2015; 11(7):1083-91. PubMed ID: 25804123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
    Subramaniam RM
    PET Clin; 2017 Jan; 12(1):1-5. PubMed ID: 27863561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics: the bridge between medical imaging and personalized medicine.
    Lambin P; Leijenaar RTH; Deist TM; Peerlings J; de Jong EEC; van Timmeren J; Sanduleanu S; Larue RTHM; Even AJG; Jochems A; van Wijk Y; Woodruff H; van Soest J; Lustberg T; Roelofs E; van Elmpt W; Dekker A; Mottaghy FM; Wildberger JE; Walsh S
    Nat Rev Clin Oncol; 2017 Dec; 14(12):749-762. PubMed ID: 28975929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in molecular preclinical therapy mediated by imaging.
    Greco A; Albanese S; Auletta L; DE Carlo F; Salvatore M; Howard CM; Claudio PP
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):76-94. PubMed ID: 27858405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive models of tumour response to treatment using functional imaging techniques.
    Marcu LG; Bezak E; Toma-Dasu I; Dasu A
    Comput Math Methods Med; 2015; 2015():571351. PubMed ID: 25838837
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear medicine in precision oncology: a foreword.
    de Geus-Oei LF; Deroose CM
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):231-233. PubMed ID: 32343513
    [No Abstract]   [Full Text] [Related]  

  • 12. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pure research imaging tool to PET-guided personalized medicine in oncology: a true revolution in modern medicine.
    Basu S
    Indian J Cancer; 2010; 47(2):98-9. PubMed ID: 20448370
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.
    Van den Abbeele AD; Krajewski KM; Tirumani SH; Fennessy FM; DiPiro PJ; Nguyen QD; Harris GJ; Jacene HA; Lefever G; Ramaiya NH
    J Am Coll Radiol; 2016 Apr; 13(4):365-71. PubMed ID: 26774886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine in pediatric oncology: Lessons learned and next steps.
    Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical imaging in oncology: advances and perspectives.
    Iommelli F; DE Rosa V; Terlizzi C; Del Vecchio S
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):33-47. PubMed ID: 27858408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging response assessment in oncology.
    Curran SD; Muellner AU; Schwartz LH
    Cancer Imaging; 2006 Oct; 6(Spec No A):S126-30. PubMed ID: 17114065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic pathology in the era of molecular medicine].
    Zhang B; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):1-3. PubMed ID: 24713240
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer Imaging in Immunotherapy.
    Eleneen Y; Colen RR
    Adv Exp Med Biol; 2017; 995():141-153. PubMed ID: 28321816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CT.
    Basu S
    Discov Med; 2012 Jan; 13(68):65-73. PubMed ID: 22284785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.